Full Transcript: Dr Ranjit Manchanda, Clinical Senior Lecturer at Barts Cancer Institute, interviewed by Erin Brodwin of Business Insider

Dr. Ranjit Manchandra (left) and Erin Brodwin (right)

On this episode of Sequenced, Dr. Ranjit Manchanda, Clinical Senior Lecturer at Barts Cancer Institute in London, sits down with Business Insider’s Erin Brodwin to discuss population-based genetic testing for cancer prevention.

Dr. Manchanda’s recent research found that population testing for multiple breast cancer genes has the potential to be both cost-effective and life-saving. Curious to learn more? The research abstract can be found here.

We’ve posted complete transcript of the podcast below. You can subscribe to Sequenced on Apple Podcasts, SoundCloud, Stitcher, and Google Play.

Full Transcript: Dr Ranjit Manchanda, Clinical Senior Lecturer at Barts Cancer Institute, interviewed by Erin Brodwin of Business Insider

What we do and whom we serve: A 10-year history of our work at Color

How 30,000 People Took More Control of Their Health: A Milestone in Accessible Personalized Medicine

Too few cancer patients receive genetic testing—after they’ve been diagnosed